Navigation Links
American Medical Association Endorses CAQH CORE Effort to Standardize and Streamline Patient Administrative Data Exchange
Date:10/29/2008

claims status and reporting of patient financial responsibility for an increased number of service codes -- uniformly adopting existing standards to do so.

Development has begun on the CORE Phase III rules, which may include steps to determine in- or out-of-network status of a provider, alternative search requirements for eligibility transactions when member ID information is missing, data regarding claims payment and status, and continuing to harmonize CORE with other industry standardization efforts. CAQH expects to launch those rules in 2009.

About CAQH

CAQH serves as a catalyst for industry collaboration on initiatives that simplify healthcare administration for health plans and providers, resulting in a better care experience for patients and caregivers. CAQH solutions help promote quality interactions between plans, providers and other stakeholders, reduce costs and frustrations associated with healthcare administration, facilitate administrative healthcare information exchange and encourage administrative and clinical data integration. Visit http://www.coreconnect.org for more information about CORE.


'/>"/>
SOURCE CAQH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report 2Health News:Specialists On Call Expands Access to Emergency Neurology On-Call Services in North Carolina 2Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 2Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 3Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 4Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 5Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 6Health News:Solos Endoscopy, Inc. Receives Purchase Order from Cleveland Clinic 2Health News:Health Care Spending in U.S. Grew at Lowest Rate in a Decade 2Health News:Health Care Spending in U.S. Grew at Lowest Rate in a Decade 3Health News:CVS/pharmacy Offers Shoppers More Than $69 Million in 'Extra Bucks' 2Health News:CVS/pharmacy Offers Shoppers More Than $69 Million in 'Extra Bucks' 3
Breaking Medicine Technology:Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 1Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 2Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 3Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 4ClariVein 28TM 29 Catheter for Varicose Veins 3A Further Clinical Trial Results to Be Presented 5019 1ClariVein 28TM 29 Catheter for Varicose Veins 3A Further Clinical Trial Results to Be Presented 5019 2NewCardio Completes 242 9 Million Private Placement 57625 1NewCardio Completes 242 9 Million Private Placement 57625 2NewCardio Completes 242 9 Million Private Placement 57625 3NewCardio Completes 242 9 Million Private Placement 57625 4